[go: up one dir, main page]

NO975155D0 - Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet - Google Patents

Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet

Info

Publication number
NO975155D0
NO975155D0 NO975155A NO975155A NO975155D0 NO 975155 D0 NO975155 D0 NO 975155D0 NO 975155 A NO975155 A NO 975155A NO 975155 A NO975155 A NO 975155A NO 975155 D0 NO975155 D0 NO 975155D0
Authority
NO
Norway
Prior art keywords
forskolin
treatment
drug
manufacture
extracts containing
Prior art date
Application number
NO975155A
Other languages
English (en)
Other versions
NO975155L (no
NO316054B1 (no
Inventor
Paolo Morazzoni
Ezio Bombardelli
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of NO975155L publication Critical patent/NO975155L/no
Publication of NO975155D0 publication Critical patent/NO975155D0/no
Publication of NO316054B1 publication Critical patent/NO316054B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
NO19975155A 1995-05-19 1997-11-10 Anvendelse av forskolin eller ekstrakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet NO316054B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITMI951023A IT1275436B (it) 1995-05-19 1995-05-19 Uso della forskolina e di estratti che la contengono per il trattamento della alcol-dipendenza
PCT/EP1996/001952 WO1996036332A1 (en) 1995-05-19 1996-05-09 Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction

Publications (3)

Publication Number Publication Date
NO975155L NO975155L (no) 1997-11-10
NO975155D0 true NO975155D0 (no) 1997-11-10
NO316054B1 NO316054B1 (no) 2003-12-08

Family

ID=11371634

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19975155A NO316054B1 (no) 1995-05-19 1997-11-10 Anvendelse av forskolin eller ekstrakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet

Country Status (17)

Country Link
US (1) US5902823A (no)
EP (1) EP0825859B1 (no)
JP (1) JP3001641B2 (no)
KR (1) KR100423486B1 (no)
CN (1) CN1099286C (no)
AT (1) ATE215368T1 (no)
AU (1) AU697449B2 (no)
CA (1) CA2221592C (no)
DE (1) DE69620394T2 (no)
DK (1) DK0825859T3 (no)
ES (1) ES2175099T3 (no)
HU (1) HU223474B1 (no)
IT (1) IT1275436B (no)
NO (1) NO316054B1 (no)
PT (1) PT825859E (no)
RU (1) RU2183455C2 (no)
WO (1) WO1996036332A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2243005T3 (es) 1997-07-30 2005-11-16 Indena S.P.A. Extracto de soja, proceso para su preparacion y composicion farmaceutica.
EP1645272A3 (en) * 1998-05-12 2008-11-05 The Endowment For Research In Human Biology, Inc. Daidzin derivatives for the treatment of alcohol dependence or alcohol abuse
US20060122261A1 (en) * 2003-11-20 2006-06-08 Muhammed Majeed [method of preparing labdane diterpene composition, preferably isoforskolin and deacetylforskolin from forskolin extract and their use for promoting lean body mass and other applications]
US20100144885A1 (en) * 2006-09-29 2010-06-10 The Board Of Trustees Of The University Of Illinois Histone acetyl transferase activators and histone deacetylase inhibitors in the treatment of alcoholism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120975A (en) * 1976-08-26 1978-10-17 Fisons Limited Method of psychiatric conditions
US4782082A (en) * 1982-12-27 1988-11-01 Schering Corporation Method for treating allergic reactions with Forskolin
IL89530A0 (en) * 1989-03-08 1989-09-10 Jeffrey J Feigenbaum Compositions containing forskolin
US5366990A (en) * 1991-11-14 1994-11-22 Reid Larry D Method for treating alcohol abuse and alcoholism

Also Published As

Publication number Publication date
AU5816396A (en) 1996-11-29
NO975155L (no) 1997-11-10
ITMI951023A0 (it) 1995-05-19
KR19990014876A (ko) 1999-02-25
US5902823A (en) 1999-05-11
KR100423486B1 (ko) 2004-06-05
EP0825859A1 (en) 1998-03-04
DK0825859T3 (da) 2002-07-29
IT1275436B (it) 1997-08-07
AU697449B2 (en) 1998-10-08
HUP9801236A3 (en) 2001-09-28
CA2221592A1 (en) 1996-11-21
JPH11500738A (ja) 1999-01-19
NO316054B1 (no) 2003-12-08
ITMI951023A1 (it) 1996-11-19
DE69620394T2 (de) 2002-10-02
WO1996036332A1 (en) 1996-11-21
CN1184422A (zh) 1998-06-10
CA2221592C (en) 2002-07-09
HUP9801236A2 (hu) 2000-06-28
ATE215368T1 (de) 2002-04-15
JP3001641B2 (ja) 2000-01-24
HU223474B1 (hu) 2004-07-28
RU2183455C2 (ru) 2002-06-20
ES2175099T3 (es) 2002-11-16
PT825859E (pt) 2002-08-30
EP0825859B1 (en) 2002-04-03
DE69620394D1 (de) 2002-05-08
HK1005651A1 (en) 1999-01-22
CN1099286C (zh) 2003-01-22

Similar Documents

Publication Publication Date Title
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
SE9402422D0 (sv) New beads for controlled release and a pharmaceutical preparation containing the same
FR2756739B1 (fr) Nouvelle formulation de budesonide
DE69626539D1 (de) topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen
MY114698A (en) A process for the isolation of galanthamine
DE69431601D1 (de) Neue verwendung von dexmedetomidin
HUP9900511A2 (hu) Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás
DE69711078D1 (de) Topische verwendung von kappa-opioidrezeptoragonisten zur behandlung von augenschmerz
ATE168265T1 (de) Zusammensetzungen zur freigabe einer aromatischen substanz in die nase
DE69715841D1 (de) Phosphatidsäure enthaltende zusammensetzungen
ATE216587T1 (de) Verwendung von ginkgo biloba extrakten zur herstellung eines medikaments
TR200000455T2 (tr) Alzheimer hastalığının tedavisinde fankinonun kullanılması.
NO975155D0 (no) Anvendelse av forskolin eller ekstakter inneholdende denne ved fremstilling av et medikament for behandling av alkoholavhengighet
FR2763592B1 (fr) Nouveaux derives glycosyles des ginkgolides, leur application en tant que medicaments et compositions pharmaceutiques les contenant
DK0866711T3 (da) Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö
ATE215525T1 (de) Stabile derivate von ubiquinol, verfahren zu ihrer herstellung und ihre pharmazeutische anwendung
NO990450L (no) Behandling av sinnslidelser
ATE221384T1 (de) Pharmazeutische zusammensetzungen zur behandlung von alkoholsucht
ATE189677T1 (de) Verfahren zur herstellung von furosemide
DE59811643D1 (de) Haarbehandlungsmittel
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
SE9500897D0 (sv) The pharmacological use of certain cystine derivatives
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon
DE69832796D1 (de) Verwendung von mizolastine zur herstellung eines arzneimittels zur behandlung von entzündungen
GEP19981196B (en) Ointment for Treatment of Keratosis

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees